[HTML][HTML] BRCA1 promoter hypermethylation in Malignant breast tumors and in the histologically normal adjacent tissues to the tumors: exploring its potential as a …
Y Oubaddou, M Oukabli, S Fenniche, A Elktaibi… - Genes, 2023 - mdpi.com
The hypermethylation status of the promoter region of the breast cancer 1 (BRCA1), a well-
known tumor suppressor gene, has been extensively investigated in the last two decades as …
known tumor suppressor gene, has been extensively investigated in the last two decades as …
The role of the tumor microenvironment in papillary thyroid microcarcinoma nodal metastasis
M Kim, CH Kwon, BH Kim - Endocrine-Related Cancer, 2024 - erc.bioscientifica.com
The genetic alterations currently identified in papillary thyroid microcarcinomas (PTMCs) are
insufficient for distinguishing tumors with aggressive features. We aimed to identify …
insufficient for distinguishing tumors with aggressive features. We aimed to identify …
Rôle de la NADPH oxydase 4 (NOX4) dans la dédifférenciation des cellules tumorales thyroïdiennes porteuses de la mutation BRAFV600E
M Radom - 2024 - theses.hal.science
La radiothérapie métabolique à l'iode 131 (RMI) constitue le traitement principal des
cancers différenciés de la thyroïde (CDT). Cette thérapie métabolique est basée sur …
cancers différenciés de la thyroïde (CDT). Cette thérapie métabolique est basée sur …